Tahir H, Mease PJ, Kavanaugh A, Reimold A, Rech J, Hall S, Geusens P, Pellet P, Delicha EM, Pricop L, Mpofu S (2019)
Publication Type: Conference contribution
Publication year: 2019
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: 151-151
Conference Proceedings Title: RHEUMATOLOGY
DOI: 10.1093/rheumatology/kez107.074
APA:
Tahir, H., Mease, P.J., Kavanaugh, A., Reimold, A., Rech, J., Hall, S.,... Mpofu, S. (2019). Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial. In RHEUMATOLOGY (pp. 151-151). Birmingham, GB: OXFORD: OXFORD UNIV PRESS.
MLA:
Tahir, Hasan, et al. "Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial." Proceedings of the Annual Conference of the British-Soceity-for-Rheumatology, Birmingham OXFORD: OXFORD UNIV PRESS, 2019. 151-151.
BibTeX: Download